ZYTOLIGHT
LIVE

Serial Number

79383070

Owner

ZytoVision GmbH

Attorney

Laurence P. Colton

Filing Date

Oct 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ZYTOLIGHT Trademark

Serial Number: 79383070 • Registration: 7583067

ZYTOLIGHT is a trademark filed by ZytoVision GmbH on October 12, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ZytoVision GmbH (6 trademarks)

Fischkai 1

Entity Type: 99

Trademark Details

Filing Date

October 12, 2023

Registration Date

December 3, 2024

Published for Opposition

October 1, 2024

Goods & Services

Medical and veterinary preparations and articles in the nature of medical diagnostic reagents for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological preparations for medical purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for medical diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; biological preparations for veterinary purposes, namely, DNA, RNA and oligonucleotide probes, being biochemical reagents, composed of biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for veterinary diagnostic purposes, namely, all for the treatment of genetic disorders and genetic aberrations in tumors; chemical preparations for medical purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; chemical preparations for veterinary purposes, namely, DNA probes, RNA probes and oligonucleotide probes, all being biochemical reagents composed of polynucleotides, biochemical substances, oligonucleotides, proteins and enzymes and antibodies, all for diagnosis of genetic disorders and genetic aberrations in tumors; diagnostic chemical reagents for medical use; chemical preparations for testing blood for blood disorders, tumor diseases, viruses, bacteria, disease diagnosis and detection, organ function, metabolic disorders, endocrine disorders, hormonal disorders, bacteria-based disorders, virus-based disorders, fungal infections for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic chemical test reagents for medical purposes; diagnostic chemical test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; diagnostic testing materials in the nature of diagnostic chemical and biological reagents for medical use; indicators for medical diagnosis in the nature of chemical and biological diagnostic reagents; clinical medical reagents; diagnostic reagents for medical use; reagents for use in diagnostic analysis for veterinary purposes; reagents for analytical diagnostic purposes for medical purposes; reagents for analytical diagnostic purposes for veterinary purposes; diagnostic reagents for in-vitro laboratory use for medical purposes; diagnostic reagents for in-vitro laboratory use for veterinary purposes; reagents for use in diagnostic tests for veterinary purposes; diagnostic reagents for microbiological analysis for medical purposes; diagnostic reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic analysis for medical purposes; reagents for use in diagnostic tests for medical purposes; diagnostic reagents for use with analyzers for veterinary purposes; diagnostic reagents for use with analyzers for medical purposes; reactants for medical diagnosis; reactants for veterinary diagnosis; veterinary diagnostic reagents

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 24, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 6, 2025 FICS
FINAL DISPOSITION PROCESSED
May 6, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 26, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 8, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 8, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 3, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 3, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 29, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 27, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 30, 2024 CNRT
ASSIGNED TO EXAMINER
May 30, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 14, 2023 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 9, 2023 SDRC